GORE EXCLUDER AAA ENDOPROSTHESIS
Report
- Report Number
- 2017233-2011-00035
- Event Type
- Injury
- Date Received
- January 21, 2011
- Date of Event
- January 20, 2011
- Report Date
- January 20, 2011
- Manufacturer
- W.L. GORE & ASSOCIATES
- Product Code
- MIH
- PMA / PMN Number
- P020004
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- IN, US
- Reporter Occupation
- PHYSICIAN
Narratives
A REVIEW OF THE MANUFACTURING PAPERWORK HAS BEEN CONDUCTED. THE REVIEW OF THE MANUFACTURING PAPERWORK VERIFIED THAT THIS LOT MET ALL PRE-RELEASE SPECIFICATIONS. AS STATED IN THE GORE EXCLUDER AAA ENDOPROSTHESIS INSTRUCTIONS FOR USE, COMPLICATIONS THAT MAY OCCUR AND/OR REQUIRE INTERVENTION INCLUDE, BUT ARE NOT LIMITED TO, ENDOLEAK. ADD'L GORE DEVICES RELATED TO THIS EVENT: (B)(4).
ON (B)(6) 2010, THE PT WAS IMPLANTED WITH THREE GORE EXCLUDER AAA ENDOPROSTHESES TO TREAT AN ABDOMINAL AORTIC ANEURYSM. IT WAS NOTED THAT THE PROXIMAL NECK ANGLE MEASURED ABOUT 70 DEGREES. A POSSIBLE TYPE-2 ENDOLEAK FROM THE LUMBAR ARTERIES WAS SUSPECTED UPON COMPLETION ANGIOGRAPHY. THE PT TOLERATED THE PROCEDURE WELL. ON (B)(6) 2011, A REINTERVENTION OCCURRED TO TREAT A PROXIMAL TYPE-1 ENDOLEAK WITH SLIGHT, INDETERMINATE ANEURYSM GROWTH. A GORE EXCLUDER AAA AORTIC EXTENDER ENDOPROSTHESIS WAS PLACED. FINAL ANGIOGRAPHY CONFIRMED A TYPE-2 ENDOLEAK FROM A LUMBAR ARTERY. THE PT TOLERATED THE PROCEDURE WELL.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | GORE EXCLUDER AAA ENDOPROSTHESIS | MIH/SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT | MIH | W.L. GORE & ASSOCIATES | WLG425 | 06833498 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 83 YR | Hospitalization| R | LASIX| (B)(4)| ASPIRIN| ATENOLOL| THYROXINE| PRAVACHOL| COUMADIN| MEDAMUCIL| ACTONEL |